Non-Hodgkin Lymphomas

Below you will find a collection of articles from Hematology, the ASH Education Program Book, written by experts in the field about current treatments for non-Hodgkin lymphomas. To learn more about the disease, please see our general information page about lymphoma. A number of links to organizations that inform and support patients with lymphoma and their families are also available.

Aggressive Lymphomas

• The Incidence, Natural History, Biology, and Treatment of Transformed Lymphomas (2009)
• Current Treatment Standards and Emerging Strategies in Mantle Cell Lymphoma (2009)
• Primary Mediastinal B-Cell Lymphoma (2008)
• Burkitt Lymphoma: Revisiting the Pathogenesis of a Virus-Associated Malignancy (2007)
• Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways (2007)
• Antibody Therapy in Aggressive Lymphomas (2007)
• Molecular Signatures Define New Rational Treatment in Large B-Cell Lymphomas (2007)
• Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond (2007)
• Vaccine Therapy for B-Cell Lymphomas: Next-Generation Strategies (2007)
• Diffuse Large B-Cell Lymphoma: Risk Stratification and Management of Relapsed Disease (2005)

General

• The 2008 WHO Classification of Lymphomas: Implications for Clinical Practice and Translational Research (2009)
• Special Problems in B-Cell Lymphoma: An Historical Perspective (2008)
• Does High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation Have a Role in the Primary Treatment of Peripheral T-Cell Lymphomas? (2008)
• Should Adolescents with NHL Be Treated as Old Children or Young Adults? (2007)
• Diagnosis and Treatment of Childhood Non-Hodgkin Lymphoma (2007)
• Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma (2006)
  
• Multimodality Therapies and Optimal Schedule of Antibodies: Rituximab in Lymphoma as an Example (2005)
• Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy (2005)
• Targeting CD20 in Follicular NHL: Novel Anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates (2005)

Indolent Lymphomas

• Allogeneic Stem Cell Transplantation in Follicular Lymphoma: Recent Progress and Controversy (2009)
• Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL (2008)
• Clinical Features, Prognosis and Treatment of Follicular Lymphoma (2007)
• Follicular NHL: From Antibodies and Vaccines to Graft-versus-Lymphoma Effects (2007)
• Controversies in Follicular Lymphoma: "Who, What, When, Where, and Why?" (Not Necessarily in That Order!) (2006)

Other

• Burkitt Lymphoma in Adults (2008)
• The Biology of the Germinal Center (2007)
• An Update on Therapy of Primary Central Nervous System Lymphoma (2006)
• Biology and Treatment of Epstein-Barr Virus-Associated Non-Hodgkin Lymphomas (2005)
  

T-Cell Lymphomas

• Peripheral T-Cell Lymphomas: An Historical Perspective (2008)
• Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas (2008)
• Prognosis and Primary Therapy in Peripheral T-Cell Lymphomas (2008)
• Novel Therapies and Role of Transplant in the Treatment of Peripheral T-Cell Lymphomas (2008)
• Engineering Antitumor Immunity by T-Cell Adoptive Immunotherapy (2007)
  
• Therapy of Peripheral T/NK Neoplasms (2006)
• Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types) (2005)

Return to Top